Dr. Usman Baber and Dr. C. Michael Gibson Discuss: TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI September 29, 2019 2019 | Cardiology | TCT Tags: 2019, Cardiology, TCT http://tv.clinicaltrialresults.org/file_repos/71/2399-2371.mp4 Download Disclosures: TBA Article Navigation Dr. Giora Weisz Presents: TCT 2019 Wrap-Up in Hebrew Advancing Cell Therapies for Coronary Microvascular Dysfunction: Experts Roundtable – Discussion